Casper Steinmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Casper Steinmann has a total of 343 co-authors. Here are the top co-authors by number of shared publications:
- Jan Halborg Jensen
Department of Chemistry, University of Copenhagen, Denmark
10 shared publications - Aled Morgan Edwards
Structural Genomics Consortium
5 shared publications - Anders Hogner
AstraZeneca
5 shared publications - Elisa Gibson
Structural Genomics Consortium
5 shared publications - Gerhard Wolber
Molecular Design Group, Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy Freie Universität Berlin Berlin Germany
5 shared publications - Hartmut Beck
Bayer (Germany)
5 shared publications
Latest Publications
- Open Access
- 17 July 2026
- Published by Springer Nature in Journal of Inclusion Phenomena and Macrocyclic Chemistry
- Vol. 106 (9-10) , 639-651
Weakly interacting cyclodextrin complexes: an experimental and theoretical methodological assessment using two fluorescent anilinonaphthalenes
2-Anilinonaphthalene-6-sulfonate (2,6-ANS) and 8-anilinonaphthalene-1-sulfonate (8,1-ANS) are polarity-sensitive fluorescent probes that serve as model systems for host–guest interactions with cyclodextrins. Reliable binding free energies with $$\alpha$$ -, $$\beta$$ -, and $$\gamma$$ -cyclodextrins are needed to exploit these probes as inexpensive, high-throughput reporters for inclusion complexes. Here, we determine the free energies of association of 2,6-ANS and 8,1-ANS to the three native cyclodextrins using fluorescence spectroscopy, isothermal titration calorimetry (ITC), and molecular simulations from either docking or MM/GBSA. Fluorescence titrations indicate that 2,6-ANS binds most strongly to $$\beta$$ -CD, whereas 8,1-ANS binds most strongly to $$\gamma$$ -CD, while ITC places the 8,1-ANS $$\gamma$$ -CD interaction among the weakest of the complexes studied. Docking simulations qualitatively support the experimental trends, whereas MM/GBSA exhibits systematic deviations, particularly for $$\gamma$$ -CD, consistent with limitations of the surface-area-based nonpolar solvation model and parameterization for carbohydrate hosts. Method disagreements are most pronounced for systems with low association constants ( $$5 \times 10^{1}\ \textrm{M}^{-1}$$ ), underscoring the need for cautious interpretation in this weak-binding regime. Molecular dynamics simulations further show that the poor fit of the naphthalene ring in the 2,6-ANS $$\alpha$$ -CD complex can lead to partial solvent exposure and distorted fluorescence readouts. For 8,1-ANS, its larger size amplifies methodological differences, with $$\gamma$$ -CD being the only host, among those examined, that can fully accommodate the naphthalene group within its cavity. Overall, these results illustrate both the utility and the limitations of combining experimental and computational approaches to analyze weak cyclodextrin inclusion complexes.- 17 July 2026
- Published by Springer Nature in Journal of Inclusion Phenomena and Macrocyclic Chemistry
- Vol. 106 (9-10) , 639-651
Open AccessWeakly interacting cyclodextrin complexes: an experimental and theoretical methodological assessment using two fluorescent anilinonaphthalenes
2-Anilinonaphthalene-6-sulfonate (2,6-ANS) and 8-anilinonaphthalene-1-sulfonate (8,1-ANS) are polarity-sensitive fluorescent probes that serve as model systems for host–guest interactions with cyclodextrins. Reliable binding free energies with $$\alpha$$ -, $$\beta$$ -, and $$\gamma$$ -cyclodextrins are needed to exploit these probes as inexpensive, high-throughput reporters for inclusion complexes. Here, we determine the free energies of association of 2,6-ANS and 8,1-ANS to the three native cyclodextrins using fluorescence spectroscopy, isothermal titration calorimetry (ITC), and molecular simulations from either docking or MM/GBSA. Fluorescence titrations indicate that 2,6-ANS binds most strongly to $$\beta$$ -CD, whereas 8,1-ANS binds most strongly to $$\gamma$$ -CD, while ITC places the 8,1-ANS $$\gamma$$ -CD interaction among the weakest of the complexes studied. Docking simulations qualitatively support the experimental trends, whereas MM/GBSA exhibits systematic deviations, particularly for $$\gamma$$ -CD, consistent with limitations of the surface-area-based nonpolar solvation model and parameterization for carbohydrate hosts. Method disagreements are most pronounced for systems with low association constants ( $$5 \times 10^{1}\ \textrm{M}^{-1}$$ ), underscoring the need for cautious interpretation in this weak-binding regime. Molecular dynamics simulations further show that the poor fit of the naphthalene ring in the 2,6-ANS $$\alpha$$ -CD complex can lead to partial solvent exposure and distorted fluorescence readouts. For 8,1-ANS, its larger size amplifies methodological differences, with $$\gamma$$ -CD being the only host, among those examined, that can fully accommodate the naphthalene group within its cavity. Overall, these results illustrate both the utility and the limitations of combining experimental and computational approaches to analyze weak cyclodextrin inclusion complexes. - Top Cited PapersOpen Access
- 21 January 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 66 (3) , 1566-1581
CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2
The third Critical Assessment of Computational Hit-finding Experiments (CACHE) challenged computational teams to identify chemically novel ligands targeting the macrodomain 1 of SARS-CoV-2 Nsp3, a promising coronavirus drug target. Twenty-three groups deployed diverse design strategies to collectively select 1739 ligand candidates. While over 85% of the designed molecules were chemically novel, the best experimentally confirmed hits were structurally similar to previously published compounds. Confirming a trend observed in CACHE #1 and #2, two of the best-performing workflows used compounds selected by physics-based computational screening methods to train machine learning models able to rapidly screen large chemical libraries, while four others used exclusively physics-based approaches. Three pharmacophore searches and one fragment growing strategy were also part of the seven winning workflows. While active molecules discovered by CACHE #3 participants largely mimicked the adenine ring of the endogenous substrate, ADP-ribose, preserving the canonical chemotype commonly observed in previously reported Nsp3-Mac1 ligands, they still provide novel structure-activity relationship insights that may inform the development of future antivirals. Collectively, these results show that multiple molecular design strategies can efficiently converge on similar potent molecules.
- 21 January 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 66 (3) , 1566-1581
Top Cited PapersOpen AccessCACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2
The third Critical Assessment of Computational Hit-finding Experiments (CACHE) challenged computational teams to identify chemically novel ligands targeting the macrodomain 1 of SARS-CoV-2 Nsp3, a promising coronavirus drug target. Twenty-three groups deployed diverse design strategies to collectively select 1739 ligand candidates. While over 85% of the designed molecules were chemically novel, the best experimentally confirmed hits were structurally similar to previously published compounds. Confirming a trend observed in CACHE #1 and #2, two of the best-performing workflows used compounds selected by physics-based computational screening methods to train machine learning models able to rapidly screen large chemical libraries, while four others used exclusively physics-based approaches. Three pharmacophore searches and one fragment growing strategy were also part of the seven winning workflows. While active molecules discovered by CACHE #3 participants largely mimicked the adenine ring of the endogenous substrate, ADP-ribose, preserving the canonical chemotype commonly observed in previously reported Nsp3-Mac1 ligands, they still provide novel structure-activity relationship insights that may inform the development of future antivirals. Collectively, these results show that multiple molecular design strategies can efficiently converge on similar potent molecules.
- Open Access
- 1 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2
The third Critical Assessment of Computational Hit-finding Experiments (CACHE) challenged computational teams to identify chemically novel ligands targeting the macrodomain 1 of SARS-CoV-2 Nsp3, a promising coronavirus drug target. Twenty-three groups deployed diverse design strategies to collectively select 1739 ligand candidates. While over 85% of the designed molecules were chemically novel, the best experimentally confirmed hits were structurally similar to previously published compounds. Confirming a trend observed in CACHE #1 and #2, two of the best-performing workflows used compounds selected by physics-based computational screening methods to train machine learning models able to rapidly screen large chemical libraries, while four others used exclusively physics-based approaches. Three pharmacophore searches and one fragment growing strategy were also part of the seven winning workflows. While active molecules discovered by CACHE #3 participants largely mimicked the adenine ring of the endogenous substrate, ADP-ribose, preserving the canonical chemotype commonly observed in previously reported Nsp3-Mac1 ligands, they still provide novel structure-activity relationship insights that may inform the development of future antivirals. Collectively, these results show that multiple molecular design strategies can efficiently converge on similar effective molecules.
- 1 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2
The third Critical Assessment of Computational Hit-finding Experiments (CACHE) challenged computational teams to identify chemically novel ligands targeting the macrodomain 1 of SARS-CoV-2 Nsp3, a promising coronavirus drug target. Twenty-three groups deployed diverse design strategies to collectively select 1739 ligand candidates. While over 85% of the designed molecules were chemically novel, the best experimentally confirmed hits were structurally similar to previously published compounds. Confirming a trend observed in CACHE #1 and #2, two of the best-performing workflows used compounds selected by physics-based computational screening methods to train machine learning models able to rapidly screen large chemical libraries, while four others used exclusively physics-based approaches. Three pharmacophore searches and one fragment growing strategy were also part of the seven winning workflows. While active molecules discovered by CACHE #3 participants largely mimicked the adenine ring of the endogenous substrate, ADP-ribose, preserving the canonical chemotype commonly observed in previously reported Nsp3-Mac1 ligands, they still provide novel structure-activity relationship insights that may inform the development of future antivirals. Collectively, these results show that multiple molecular design strategies can efficiently converge on similar effective molecules.
- 20 June 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (13) , 6884-6898
CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13
A critical assessment of computational hit-finding experiments (CACHE) challenge was conducted to predict ligands for the SARS-CoV-2 Nsp13 helicase RNA binding site, a highly conserved COVID-19 target. Twenty-three participating teams comprised of computational chemists and data scientists used protein structure and data from fragment-screening paired with advanced computational and machine learning methods to each predict up to 100 inhibitory ligands. Across all teams, 1957 compounds were predicted and were subsequently procured from commercial catalogs for biophysical assays. Of these compounds, 0.7% were confirmed to bind to Nsp13 in a surface plasmon resonance assay. The six best-performing computational workflows used fragment growing, active learning, or conventional virtual screening with and without complementary deep-learning scoring functions. Follow-up functional assays resulted in identification of two compound scaffolds that bound Nsp13 with a Kd below 10 μM and inhibited in vitro helicase activity. Overall, CACHE #2 participants were successful in identifying hit compound scaffolds targeting Nsp13, a central component of the coronavirus replication-transcription complex. Computational design strategies recurrently successful across the first two CACHE challenges include linking or growing docked or crystallized fragments and docking small and diverse libraries to train ultrafast machine-learning models. The CACHE #2 competition reveals how crowd-sourcing ligand prediction efforts using a distinct array of approaches followed with critical biophysical assays can result in novel lead compounds to advance drug discovery efforts.
- 20 June 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (13) , 6884-6898
CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13
A critical assessment of computational hit-finding experiments (CACHE) challenge was conducted to predict ligands for the SARS-CoV-2 Nsp13 helicase RNA binding site, a highly conserved COVID-19 target. Twenty-three participating teams comprised of computational chemists and data scientists used protein structure and data from fragment-screening paired with advanced computational and machine learning methods to each predict up to 100 inhibitory ligands. Across all teams, 1957 compounds were predicted and were subsequently procured from commercial catalogs for biophysical assays. Of these compounds, 0.7% were confirmed to bind to Nsp13 in a surface plasmon resonance assay. The six best-performing computational workflows used fragment growing, active learning, or conventional virtual screening with and without complementary deep-learning scoring functions. Follow-up functional assays resulted in identification of two compound scaffolds that bound Nsp13 with a Kd below 10 μM and inhibited in vitro helicase activity. Overall, CACHE #2 participants were successful in identifying hit compound scaffolds targeting Nsp13, a central component of the coronavirus replication-transcription complex. Computational design strategies recurrently successful across the first two CACHE challenges include linking or growing docked or crystallized fragments and docking small and diverse libraries to train ultrafast machine-learning models. The CACHE #2 competition reveals how crowd-sourcing ligand prediction efforts using a distinct array of approaches followed with critical biophysical assays can result in novel lead compounds to advance drug discovery efforts.
- Open Access
- 18 April 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Finding Drug Candidate Hits With a Hundred Samples: Ultra-low Data Screening With Active Learning
Active learning (AL) can significantly accelerate drug discovery by iteratively selecting informative molecules, reducing experimental workload. However, existing AL studies typically assume access to large datasets, an unrealistic scenario for most academic labs. Here, we investigate AL strategies tailored specifically for small-scale molecular screening, using only 110 affinity evaluations approximated by docking scores from realistic compound libraries: the Developmental Therapeutics Program repository (DTP) and Enamine Discovery Diversity Set 10 (DDS-10). Among 20 tested combinations of molecular descriptors and machine learning models, we identify Continuous and Data-Driven Descriptors (CDDD) combined with a Multi-Layer Perceptron (MLP), augmented by the Pairwise Difference Regression (PADRE) data augmentation technique, as optimal. This combination achieves a 97% probability of discovering at least five top-1% hits from DTP using only 110 affinity evaluations, even under simulated experimental uncertainty. Similarly, the DDS-10 dataset achieves a 100% probability of discovering at least five top-1% hits from DDS-10 using only 110 affinity evaluations. Incorporating prior knowledge by enriching initial datasets with a single known hit molecule further increases this probability. Our findings underscore the feasibility and substantial potential of AL for small-scale drug discovery in resource-limited environments. Our results suggest that early in the AL search the algorithm benefits from accurately quantifying the binding strengths of very weak binders.
- 18 April 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessFinding Drug Candidate Hits With a Hundred Samples: Ultra-low Data Screening With Active Learning
Active learning (AL) can significantly accelerate drug discovery by iteratively selecting informative molecules, reducing experimental workload. However, existing AL studies typically assume access to large datasets, an unrealistic scenario for most academic labs. Here, we investigate AL strategies tailored specifically for small-scale molecular screening, using only 110 affinity evaluations approximated by docking scores from realistic compound libraries: the Developmental Therapeutics Program repository (DTP) and Enamine Discovery Diversity Set 10 (DDS-10). Among 20 tested combinations of molecular descriptors and machine learning models, we identify Continuous and Data-Driven Descriptors (CDDD) combined with a Multi-Layer Perceptron (MLP), augmented by the Pairwise Difference Regression (PADRE) data augmentation technique, as optimal. This combination achieves a 97% probability of discovering at least five top-1% hits from DTP using only 110 affinity evaluations, even under simulated experimental uncertainty. Similarly, the DDS-10 dataset achieves a 100% probability of discovering at least five top-1% hits from DDS-10 using only 110 affinity evaluations. Incorporating prior knowledge by enriching initial datasets with a single known hit molecule further increases this probability. Our findings underscore the feasibility and substantial potential of AL for small-scale drug discovery in resource-limited environments. Our results suggest that early in the AL search the algorithm benefits from accurately quantifying the binding strengths of very weak binders.
- Open Access
- 5 March 2025
- Published by American Chemical Society (ACS) in ChemRxiv
CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13
A critical assessment of computational hit finding experiments (CACHE) challenge was conducted to predict ligands for the SARS-CoV-2 Nsp13 helicase RNA binding site, a highly conserved COVID-19 target. Twenty-three participating teams comprised of computational chemists and data scientists used protein structure and data from fragment-screening paired with advanced computational and machine learning methods to each predict up to 100 inhibitory ligands. Across all teams, 1957 compounds were predicted and were subsequently procured from commercial catalogs for biophysical assays. Of these compounds, 0.7% were confirmed to bind to Nsp13 in a surface plasmon resonance assay. The six best performing computational workflows used fragment growing, active learning, or conventional virtual screening with and without complementary deep-learning scoring functions. Follow-up functional assays resulted in identification of two compound scaffolds that bound Nsp13 with a Kd below 10 µM and inhibited in vitro helicase activity. Overall, the CACHE #2 was successful in identifying hit compound scaffolds targeting Nsp13, a central component of the coronavirus replication-transcription complex. Computational design strategies recurrently successful across the first two CACHE challenges include linking or growing docked or crystallized fragments and docking small and diverse libraries to train ultra-fast machine-learning models. The CACHE#2 competition reveals how crowd-sourcing ligand prediction efforts using a distinct array of approaches followed with critical biophysical assays can result in novel lead compounds to advance drug discovery efforts.
- 5 March 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13
A critical assessment of computational hit finding experiments (CACHE) challenge was conducted to predict ligands for the SARS-CoV-2 Nsp13 helicase RNA binding site, a highly conserved COVID-19 target. Twenty-three participating teams comprised of computational chemists and data scientists used protein structure and data from fragment-screening paired with advanced computational and machine learning methods to each predict up to 100 inhibitory ligands. Across all teams, 1957 compounds were predicted and were subsequently procured from commercial catalogs for biophysical assays. Of these compounds, 0.7% were confirmed to bind to Nsp13 in a surface plasmon resonance assay. The six best performing computational workflows used fragment growing, active learning, or conventional virtual screening with and without complementary deep-learning scoring functions. Follow-up functional assays resulted in identification of two compound scaffolds that bound Nsp13 with a Kd below 10 µM and inhibited in vitro helicase activity. Overall, the CACHE #2 was successful in identifying hit compound scaffolds targeting Nsp13, a central component of the coronavirus replication-transcription complex. Computational design strategies recurrently successful across the first two CACHE challenges include linking or growing docked or crystallized fragments and docking small and diverse libraries to train ultra-fast machine-learning models. The CACHE#2 competition reveals how crowd-sourcing ligand prediction efforts using a distinct array of approaches followed with critical biophysical assays can result in novel lead compounds to advance drug discovery efforts.
- 5 November 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (22) , 8521-8536
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson’s Disease Associated Protein
The CACHE challenges are a series of prospective benchmarking exercises to evaluate progress in the field of computational hit-finding. Here we report the results of the inaugural CACHE challenge in which 23 computational teams each selected up to 100 commercially available compounds that they predicted would bind to the WDR domain of the Parkinson's disease target LRRK2, a domain with no known ligand and only an apo structure in the PDB. The lack of known binding data and presumably low druggability of the target is a challenge to computational hit finding methods. Of the 1955 molecules predicted by participants in Round 1 of the challenge, 73 were found to bind to LRRK2 in an SPR assay with a KD lower than 150 μM. These 73 molecules were advanced to the Round 2 hit expansion phase, where computational teams each selected up to 50 analogs. Binding was observed in two orthogonal assays for seven chemically diverse series, with affinities ranging from 18 to 140 μM. The seven successful computational workflows varied in their screening strategies and techniques. Three used molecular dynamics to produce a conformational ensemble of the targeted site, three included a fragment docking step, three implemented a generative design strategy and five used one or more deep learning steps. CACHE #1 reflects a highly exploratory phase in computational drug design where participants adopted strikingly diverging screening strategies. Machine learning-accelerated methods achieved similar results to brute force (e.g., exhaustive) docking. First-in-class, experimentally confirmed compounds were rare and weakly potent, indicating that recent advances are not sufficient to effectively address challenging targets.
- 5 November 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (22) , 8521-8536
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson’s Disease Associated Protein
The CACHE challenges are a series of prospective benchmarking exercises to evaluate progress in the field of computational hit-finding. Here we report the results of the inaugural CACHE challenge in which 23 computational teams each selected up to 100 commercially available compounds that they predicted would bind to the WDR domain of the Parkinson's disease target LRRK2, a domain with no known ligand and only an apo structure in the PDB. The lack of known binding data and presumably low druggability of the target is a challenge to computational hit finding methods. Of the 1955 molecules predicted by participants in Round 1 of the challenge, 73 were found to bind to LRRK2 in an SPR assay with a KD lower than 150 μM. These 73 molecules were advanced to the Round 2 hit expansion phase, where computational teams each selected up to 50 analogs. Binding was observed in two orthogonal assays for seven chemically diverse series, with affinities ranging from 18 to 140 μM. The seven successful computational workflows varied in their screening strategies and techniques. Three used molecular dynamics to produce a conformational ensemble of the targeted site, three included a fragment docking step, three implemented a generative design strategy and five used one or more deep learning steps. CACHE #1 reflects a highly exploratory phase in computational drug design where participants adopted strikingly diverging screening strategies. Machine learning-accelerated methods achieved similar results to brute force (e.g., exhaustive) docking. First-in-class, experimentally confirmed compounds were rare and weakly potent, indicating that recent advances are not sufficient to effectively address challenging targets.
- Open Access
Pd EnCat™ 30 Recycling in Suzuki Cross-Coupling Reactions
Pd EnCat™ 30 is a palladium catalyst broadly used in several hydrogenation and cross-coupling reactions. It is known for its numerous beneficial features, which include high-yielding performance, easy recovery, and reusability. However, the available data regarding its recyclability in Suzuki coupling reactions are limited to a few reaction cycles and, therefore, fail to explore its full potential. Our work focuses on investigating the extent of Pd EnCat™ 30 reusability in Suzuki cross-coupling reactions by measuring its performance according to isolated yields of product. Our findings demonstrate that Pd EnCat™ 30 can be reused over a minimum of 30 reaction cycles, which is advantageous in terms of cost reduction and more sustainable chemical production.
Open AccessPd EnCat™ 30 Recycling in Suzuki Cross-Coupling Reactions
Pd EnCat™ 30 is a palladium catalyst broadly used in several hydrogenation and cross-coupling reactions. It is known for its numerous beneficial features, which include high-yielding performance, easy recovery, and reusability. However, the available data regarding its recyclability in Suzuki coupling reactions are limited to a few reaction cycles and, therefore, fail to explore its full potential. Our work focuses on investigating the extent of Pd EnCat™ 30 reusability in Suzuki cross-coupling reactions by measuring its performance according to isolated yields of product. Our findings demonstrate that Pd EnCat™ 30 can be reused over a minimum of 30 reaction cycles, which is advantageous in terms of cost reduction and more sustainable chemical production.
- Open Access
- 2 August 2024
- Published by MDPI AG in Preprints.org
Pd EnCat™ 30 Recycling in Suzuki Cross-Coupling Reactions
Pd EnCat™ 30 is a palladium catalyst broadly used in several hydrogenation and cross-coupling reactions. It is known for its numerous beneficial features, which include high-yielding performance, easy recovery, and reusability. However, the available data regarding its recyclability in Suzuki coupling reactions are limited to a few reaction cycles and, therefore, fail to explore its full potential. Our work focuses on investigating the extent of Pd EnCat™ 30 reusability in Suzuki cross-coupling reactions by measuring its performance according to isolated yields of product. Our findings demonstrate that Pd EnCat™ 30 can be reused over a minimum of 30 reaction cycles, which is advantageous in terms of cost reduction and more sustainable chemical production.
- 2 August 2024
- Published by MDPI AG in Preprints.org
Open AccessPd EnCat™ 30 Recycling in Suzuki Cross-Coupling Reactions
Pd EnCat™ 30 is a palladium catalyst broadly used in several hydrogenation and cross-coupling reactions. It is known for its numerous beneficial features, which include high-yielding performance, easy recovery, and reusability. However, the available data regarding its recyclability in Suzuki coupling reactions are limited to a few reaction cycles and, therefore, fail to explore its full potential. Our work focuses on investigating the extent of Pd EnCat™ 30 reusability in Suzuki cross-coupling reactions by measuring its performance according to isolated yields of product. Our findings demonstrate that Pd EnCat™ 30 can be reused over a minimum of 30 reaction cycles, which is advantageous in terms of cost reduction and more sustainable chemical production.
- Open Access
- 25 July 2024
- Published by AIP Publishing in The Journal of Chemical Physics
- Vol. 161 (4)
cclib 2.0: An updated architecture for interoperable computational chemistry
Interoperability in computational chemistry is elusive, impeded by the independent development of software packages and idiosyncratic nature of their output files. The cclib library was introduced in 2006 as an attempt to improve this situation by providing a consistent interface to the results of various quantum chemistry programs. The shared API across programs enabled by cclib has allowed users to focus on results as opposed to output and to combine data from multiple programs or develop generic downstream tools. Initial development, however, did not anticipate the rapid progress of computational capabilities, novel methods, and new programs; nor did it foresee the growing need for customizability. Here, we recount this history and present cclib 2, focused on extensibility and modularity. We also introduce recent design pivots—the formalization of cclib’s intermediate data representation as a tree-based structure, a new combinator-based parser organization, and parsed chemical properties as extensible objects.
- 25 July 2024
- Published by AIP Publishing in The Journal of Chemical Physics
- Vol. 161 (4)
Open Accesscclib 2.0: An updated architecture for interoperable computational chemistry
Interoperability in computational chemistry is elusive, impeded by the independent development of software packages and idiosyncratic nature of their output files. The cclib library was introduced in 2006 as an attempt to improve this situation by providing a consistent interface to the results of various quantum chemistry programs. The shared API across programs enabled by cclib has allowed users to focus on results as opposed to output and to combine data from multiple programs or develop generic downstream tools. Initial development, however, did not anticipate the rapid progress of computational capabilities, novel methods, and new programs; nor did it foresee the growing need for customizability. Here, we recount this history and present cclib 2, focused on extensibility and modularity. We also introduce recent design pivots—the formalization of cclib’s intermediate data representation as a tree-based structure, a new combinator-based parser organization, and parsed chemical properties as extensible objects.